Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
2.760
-0.120 (-4.17%)
At close: Apr 1, 2025, 4:00 PM
2.807
+0.047 (1.71%)
After-hours: Apr 1, 2025, 6:14 PM EDT

Fulcrum Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Net Income
-9.73-97.34-109.87-80.85-70.82
Upgrade
Depreciation & Amortization
1.592.172.412.522.38
Upgrade
Loss (Gain) From Sale of Investments
-4.39-5.990.150.67-0.07
Upgrade
Stock-Based Compensation
14.5514.813.3511.077.35
Upgrade
Other Operating Activities
---0--
Upgrade
Change in Accounts Receivable
-1.56-0.313.41-1.11-2.53
Upgrade
Change in Accounts Payable
-1.59-0.85-1.180.971.77
Upgrade
Change in Unearned Revenue
--0.93-3.78-13.177.88
Upgrade
Change in Other Net Operating Assets
-1.1-2.52-1.551.410.38
Upgrade
Operating Cash Flow
-2.22-90.97-97.05-78.48-53.66
Upgrade
Capital Expenditures
-0.28-0.51-1.96-1.71-1.34
Upgrade
Investment in Securities
32.51-36.1814.38-127.96-55.8
Upgrade
Investing Cash Flow
32.23-36.6912.41-129.67-57.14
Upgrade
Long-Term Debt Repaid
----0.02-0.05
Upgrade
Net Debt Issued (Repaid)
----0.02-0.05
Upgrade
Issuance of Common Stock
2.75118.1284.32186.5371.38
Upgrade
Other Financing Activities
-----0.19
Upgrade
Financing Cash Flow
2.75118.1284.32186.5171.13
Upgrade
Net Cash Flow
32.76-9.54-0.31-21.64-39.66
Upgrade
Free Cash Flow
-2.5-91.47-99.01-80.19-55
Upgrade
Free Cash Flow Margin
-3.12%-3261.07%-1561.23%-418.47%-623.34%
Upgrade
Free Cash Flow Per Share
-0.04-1.49-2.20-2.27-2.17
Upgrade
Cash Interest Paid
----0
Upgrade
Levered Free Cash Flow
-2.08-56.72-58.12-47.54-24.98
Upgrade
Unlevered Free Cash Flow
-2.08-56.72-58.12-47.54-24.98
Upgrade
Change in Net Working Capital
5.554.021.848.75-11.39
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q